GlobeNewswire Inc.··NaAcumen Pharma to Present Alzheimer's Drug Data at BofA Conference
Acumen Pharma to present at BofA Securities conference May 14 ahead of late-2026 Alzheimer's drug trial results.
ABOSmonoclonal antibodyclinical-stage biopharmaceutical